Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope.
作者信息
Chue Ben M
机构信息
Seattle Cancer Treatment and Wellness Center, University of Washington School of Medicine, Seattle, Washington.
出版信息
Gastrointest Cancer Res. 2009 Sep;3(5):208-11.
Abstract
摘要
相似文献
1
Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope.
Gastrointest Cancer Res. 2009 Sep;3(5):208-11.
2
Sustaining hope and life courage in patients undergoing ovarian cancer surgery - the impact of care.
Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12562. Epub 2016 Aug 23.
3
Entrepreneurs' Courage, Psychological Capital, and Life Satisfaction.
Front Psychol. 2019 Apr 5;10:789. doi: 10.3389/fpsyg.2019.00789. eCollection 2019.
4
Long-term survival for pancreatic cancer: a matter of hope, courage, or genetics?
Gastrointest Cancer Res. 2011 Mar;4(2):67.
5
Positive personal resources and psychological distress during the COVID-19 pandemic: resilience, optimism, hope, courage, trait mindfulness, and self-efficacy in breast cancer patients and survivors.
Support Care Cancer. 2022 Aug;30(8):7005-7014. doi: 10.1007/s00520-022-07123-1. Epub 2022 May 17.
6
Courage as Mediator between Positive Resources and General/Domain-Specific Well-Being Indices.
Eur J Investig Health Psychol Educ. 2022 Aug 13;12(8):1067-1081. doi: 10.3390/ejihpe12080076.
7
Challenges and Role Changes in Caring for Adult Children With Cancer.
J Adv Pract Oncol. 2018 Sep-Oct;9(6):634-638. Epub 2018 Sep 1.
8
Natural History and Treatment Trends in Pancreatic Cancer Subtypes.
J Gastrointest Surg. 2019 Apr;23(4):768-778. doi: 10.1007/s11605-019-04113-3. Epub 2019 Jan 31.
9
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.
J Nucl Cardiol. 2006 Sep;13(5):685-98. doi: 10.1016/j.nuclcard.2006.06.134.
10
Regional variation in courage and entrepreneurship: The contrasting role of courage for the emergence and survival of start-ups in the United States.
J Pers. 2019 Oct;87(5):1039-1055. doi: 10.1111/jopy.12454. Epub 2019 Feb 10.
引用本文的文献
1
Low extracellular pH enhances TRAIL-induced apoptosis by downregulating Mcl-1 expression.
Exp Cell Res. 2025 Apr 1;447(1):114481. doi: 10.1016/j.yexcr.2025.114481. Epub 2025 Feb 28.
2
Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type.
J Clin Med. 2024 Aug 25;13(17):5034. doi: 10.3390/jcm13175034.
3
Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years).
Medicine (Baltimore). 2019 Sep;98(38):e17251. doi: 10.1097/MD.0000000000017251.
4
Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis.
Oncologist. 2019 Dec;24(12):1543-1548. doi: 10.1634/theoncologist.2018-0786. Epub 2019 Jun 4.
5
Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease.
Medicine (Baltimore). 2019 Apr;98(16):e15302. doi: 10.1097/MD.0000000000015302.
6
Metastatic pancreatic adenocarcinoma presenting as an occipital haemorrhage.
BMJ Case Rep. 2018 Aug 1;2018:bcr-2018-224354. doi: 10.1136/bcr-2018-224354.
7
Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis.
Target Oncol. 2018 Aug;13(4):461-468. doi: 10.1007/s11523-018-0572-3.
8
Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma.
Prz Gastroenterol. 2016;11(3):155-162. doi: 10.5114/pg.2016.61438. Epub 2016 Jul 22.
9
Methylseleninic acid suppresses pancreatic cancer growth involving multiple pathways.
Nutr Cancer. 2014;66(2):295-307. doi: 10.1080/01635581.2014.868911. Epub 2014 Jan 21.
10
Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry.
J Oncol. 2012;2012:168303. doi: 10.1155/2012/168303. Epub 2012 Feb 15.
本文引用的文献
1
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.
J Clin Oncol. 2013 Nov 1;31(31):3926-34. doi: 10.1200/JCO.2012.47.3983. Epub 2013 Oct 7.
2
Tumor angiogenesis.
N Engl J Med. 2008 May 8;358(19):2039-49. doi: 10.1056/NEJMra0706596.
3
Weekly paclitaxel in the adjuvant treatment of breast cancer.
N Engl J Med. 2008 Apr 17;358(16):1663-71. doi: 10.1056/NEJMoa0707056.
4
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
J Clin Oncol. 2008 Apr 1;26(10):1642-9. doi: 10.1200/JCO.2007.11.6699.
5
Taming vessels to treat cancer.
Sci Am. 2008 Jan;298(1):56-63. doi: 10.1038/scientificamerican0108-56.
6
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
J Clin Oncol. 2008 Jan 20;26(3):374-9. doi: 10.1200/JCO.2007.12.5906.
7
Targets, trials, and travails in pancreas cancer.
J Natl Compr Canc Netw. 2007 Nov;5(10):1042-53. doi: 10.6004/jnccn.2007.0087.
8
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
J Clin Oncol. 2007 Aug 1;25(22):3230-7. doi: 10.1200/JCO.2006.10.5437.
9
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.
Oncologist. 2007 Mar;12(3):312-9. doi: 10.1634/theoncologist.12-3-312.
10
"Will weekly work"? Seems to be so...
J Clin Oncol. 2005 Sep 1;23(25):5873-4. doi: 10.1200/JCO.2005.05.031. Epub 2005 Aug 8.
Zotero 插件